Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Drug Policy in the Czech Republic.

Skoupá J.

Value Health Reg Issues. 2017 Sep;13:55-58. doi: 10.1016/j.vhri.2017.08.002. Epub 2017 Sep 9.

PMID:
29073989
2.

Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries.

Kawalec P, Stawowczyk E, Tesar T, Skoupa J, Turcu-Stiolica A, Dimitrova M, Petrova GI, Rugaja Z, Männik A, Harsanyi A, Draganic P.

Front Pharmacol. 2017 Jun 8;8:288. doi: 10.3389/fphar.2017.00288. eCollection 2017.

3.

[Treatment of Macular Oedema due to retinal vein occlusion with OZURDEX].

Studnička J, Dusová J, Skoupá J, Řehák J.

Cesk Slov Oftalmol. 2015 Aug;71(4):199-203. Czech.

PMID:
26395854
5.

[Centres for Tobacco-Dependent in the Czech Republic in 2012: overview and economy].

Králíková E, Kmeťová A, Felbrová V, Kulovaná S, Rameš J, Stěpánková L, Zvolská K, Skoupá J.

Cas Lek Cesk. 2014;153(5):246-50. Czech.

PMID:
25370771
6.

Health Economic Data Requirements and Availability in the European Union: Results of a Survey Among 10 European Countries.

Skoupá J, Annemans L, Hájek P.

Value Health Reg Issues. 2014 Sep;4:53-57. doi: 10.1016/j.vhri.2014.06.003. Epub 2014 Aug 2.

PMID:
29702807
7.

Persistence with first line anticholinergic medication in treatment-naïve overactive bladder patients.

Krhut J, Gärtner M, Petzel M, Sykora R, Nemec D, Tvrdik J, Skoupa J.

Scand J Urol. 2014 Feb;48(1):79-83. doi: 10.3109/21681805.2013.814707. Epub 2013 Jul 22.

PMID:
23870042
8.

Economic and clinical comparison of atypical depot antipsychotic drugs for treatment of chronic schizophrenia in the Czech Republic.

Einarson TR, Zilbershtein R, Skoupá J, Veselá S, Garg M, Hemels ME.

J Med Econ. 2013 Sep;16(9):1089-95. doi: 10.3111/13696998.2013.820193. Epub 2013 Jul 9.

PMID:
23808900
9.

Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries.

Orlewska E, Ancuta I, Anic B, Codrenau C, Damjanov N, Djukic P, Ionescu R, Marinchev L, Nasonov EL, Peets T, Praprotnik S, Rashkov R, Skoupa J, Tlustochowicz W, Tlustochowicz M, Tomsic M, Veldi T, Vojinovic J, Wiland P.

Med Sci Monit. 2011 Apr;17(4):SR1-13.

10.

Costs of illness and care in Parkinson's disease: an evaluation in six countries.

von Campenhausen S, Winter Y, Rodrigues e Silva A, Sampaio C, Ruzicka E, Barone P, Poewe W, Guekht A, Mateus C, Pfeiffer KP, Berger K, Skoupa J, Bötzel K, Geiger-Gritsch S, Siebert U, Balzer-Geldsetzer M, Oertel WH, Dodel R, Reese JP.

Eur Neuropsychopharmacol. 2011 Feb;21(2):180-91. doi: 10.1016/j.euroneuro.2010.08.002.

PMID:
20888737
11.

Challenges in economic evaluation of new drugs: experience with rituximab in Hungary.

Brodszky V, Orlewska E, Pentek M, Karpati K, Skoupa J, Gulacsi L.

Med Sci Monit. 2010 Jan;16(1):SR1-5.

PMID:
20037504
12.

Costs of Parkinson's disease in eastern Europe: a Czech cohort study.

Winter Y, von Campenhausen S, Brozova H, Skoupa J, Reese JP, Bötzel K, Eggert K, Oertel WH, Dodel R, Ruzicka E.

Parkinsonism Relat Disord. 2010 Jan;16(1):51-6. doi: 10.1016/j.parkreldis.2009.07.005. Epub 2009 Aug 8.

PMID:
19665915
13.

Efficacy of isotonic nasal wash (seawater) in the treatment and prevention of rhinitis in children.

Slapak I, Skoupá J, Strnad P, Horník P.

Arch Otolaryngol Head Neck Surg. 2008 Jan;134(1):67-74. doi: 10.1001/archoto.2007.19.

PMID:
18209140

Supplemental Content

Loading ...
Support Center